The Biotech Growth Trust (LON:BIOG) Posts Quarterly Earnings Results

The Biotech Growth Trust (LON:BIOG) posted its quarterly earnings data on Thursday. The company reported GBX (1) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The Biotech Growth Trust had a return on equity of 26.96% and a net margin of 95.33%.

The Biotech Growth Trust Price Performance

Shares of The Biotech Growth Trust stock opened at GBX 1,185 on Friday. The stock has a market cap of £263.73 million, a P/E ratio of -4.52 and a beta of 0.50. The company has a debt-to-equity ratio of 11.02, a quick ratio of 0.00 and a current ratio of 0.59. The Biotech Growth Trust has a one year low of GBX 612.70 and a one year high of GBX 1,225.55. The stock’s fifty day moving average is GBX 1,073.37 and its 200 day moving average is GBX 888.26.

Insider Buying and Selling at The Biotech Growth Trust

In related news, insider Julie Tankard bought 369 shares of the business’s stock in a transaction that occurred on Wednesday, October 15th. The stock was bought at an average cost of GBX 1,072 per share, with a total value of £3,955.68. Corporate insiders own 1.50% of the company’s stock.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).